Novel in vitro and in vivo assays have been developed to improve the reliability of tools employed for identification of genotoxic hazard. Several of the new assays can provide insight into mode-of-action (MoA). As emerging technologies generally used for evaluating human hazard and/or risk, these novel assays require rigorous evaluation and validation before use in a regulatory setting. Validating novel toxicology assaysis a continuing labor-intensive challenge. More specifically, many questions arise around choosing reference compounds, and comparing results against the current standard battery used for genotoxicity testing.
Save the date! HESI DART Committee and European Teratology Society Workshop on Thyroid Hormone Assessment: Implications for Developmental and Reproductive Toxicology
Register now to celebrate 30 years of HESI science! This year’s program will bridge our past achievements and future plans to generate science for improved decision-making, enhanced human health and safety, and protected environments.
2019 Safety Pharmacology Society (SPS) Annual Meeting
Centre de Convencions Internacional de Barcelona
September 23–26, 2019
For more information regarding the agenda and to register for the meeting, please visit the website.